Thomas Hitchcock, Ph.D.

Thomas Hitchcock's Title

Thomas Hitchcock, Ph.D., serves as the Chief Science Officer, a role that leverages his extensive background in genetics and biomedical research. As Chief Science Officer, Dr. Hitchcock is responsible for guiding the scientific direction and research initiatives of his organization. His leadership ensures that the latest scientific advancements are integrated into the company’s strategic goals, fostering innovation and maintaining a competitive edge in the industry.

Thomas Hitchcock's Education and Expertise

Dr. Thomas Hitchcock earned his Ph.D. in Genetics from Clemson University, a prestigious institution known for its rigorous academic programs. Following his doctoral studies, he completed post-doctoral trainings at Duke University and Yale University, specializing in Biomedical Engineering, Vascular Biology, and Therapeutics. These experiences provided him with a robust foundation in cutting-edge research methodologies and advanced scientific principles. His research at Weill Cornell Medical College, particularly in multiple myeloma genetics, further solidified his expertise in the field. With over 15 years of research experience spanning Basic Science, Proof-of-Concept, Pre-Clinical, and Clinical Research, Dr. Hitchcock is a distinguished expert in his domain.

Thomas Hitchcock's Background

Thomas Hitchcock's career is marked by significant contributions to both the academic and corporate worlds. He has worked in dermatology at innovative companies such as Ulthera, Inc., and founded Xycrobe Therapeutics Inc., where he served as CEO until its acquisition by Crown in 2019. His role as Acting Chief Scientific Officer at Bellus Medical from its inception in 2013 up to its acquisition by Crown Laboratories highlights his leadership capabilities and his knack for driving scientific advancements in burgeoning companies. Currently, Dr. Hitchcock also contributes to academia as an adjunct faculty member at the East Tennessee State University Department of Biomedical Science.

Thomas Hitchcock's Achievements

Dr. Thomas Hitchcock's achievements are manifold, reflecting his profound impact on the scientific community and industry. Notably, he founded Xycrobe Therapeutics Inc., leading it successfully until its acquisition, which underscores his entrepreneurial prowess. His tenure as Acting Chief Scientific Officer at Bellus Medical saw the company through critical phases of development and eventual acquisition. Additionally, his research contributions, particularly in the genetics of multiple myeloma, have been influential. Dr. Hitchcock also engages in public science education through his docuseries 'Beauty & the Bacteria' and the 'Skin Science Podcast Series,' where he explores and discusses pressing issues in dermatology and aesthetics.

Thomas Hitchcock's Company

Thomas Hitchcock founded Xycrobe Therapeutics Inc., a company focused on harnessing the power of the skin microbiome for therapeutic purposes. Under his leadership, the company developed innovative approaches to dermatological treatments, pioneering new frontiers in skin health. The acquisition of Xycrobe by Crown in 2019 was a testament to the company's groundbreaking work and commercial potential. Dr. Hitchcock's vision and scientific acumen were pivotal in establishing Xycrobe as a key player in the dermatology sector.